EGFR基因突变与肿瘤标志物检测在肺部占位病变鉴别诊断中的价值研究  

Research of EGFR gene mutations and tumor markers expression in lung placeholder lesions for differential diagnosis

作　　者：邹传伟[1] 王小拍[1] 周丽霞[1] 

机构地区：[1]广州市第一人民医院,广州510180

出　　处：《广州医药》2017年第3期1-6,11,共7页Guangzhou Medical Journal

摘　　要：目的研究EGFR基因突变与系列肿瘤标志物在160例原发性肺癌患者及51例肺部良性占位病变患者中的表达状况,为肺部占位病变的诊断、鉴别诊断和治疗提供参考依据。方法 160例肺癌患者取新鲜病理组织标本,采用扩增阻滞突变系统荧光PCR(ARMS-PCR)技术检测EGER基因突变;160例肺癌患者和51例良性占位病变患者取外周静脉血用化学发光法检测系列肿瘤标志物,用χ2检验统计分析数据。结果 160例肺癌病例中,EGFR基因野生型比率为47.56%(78/164),EGFR基因突变型比率为52.44%(86/164),突变型中21L858R点突变占23.17%(38/164),19Del缺失突变占22.56%(37/164)。肺癌组中系列肿瘤标志物较良性占位组具显著高表达,P<0.01。差异有统计学意义。结论肺癌致病与EGFR基因突变、肿瘤标志物高表达有显著正相关,通过肿瘤标志物和EGFR基因突变检测,结合影像学检查,将有助于肺部占位病变诊断和鉴别诊断,并为治疗手段选择提供参考依据。Objective To research EGFR gene mutation and series of tumor markers expression in 160 patients with primary lung cancer and 51 patients with lung benign placeholder lesions, provide some references for the diagnosis, differential diagnosis and treatment in lung placeholder lesions. Methods We took fresh pathological tissue specimens from 160 cases of patients with lung cancer, Then used ARMS PCR technique to detect EGER gene mutations. We took the peripheral venous blood in 160 patients with lung cancer and 51 patients with lung benign plaeeholder lesions, with chemiluminescence method to detect series of tumor markers, and used the chi-square test to statistic and analysis data. Results In 160 cases of lung cancer patients, The EGFR gene wild type rate was 47. 56% （78/164）. The EGFR gene mutation type rate was 52.44% （86/164）. In EGFR gene mutation type, The proportion of 21L858R mutation was 23.17% （38/164）, 19del mutation was 22. 56% （37/164）. Series of tumor markers had significantly higher expression in lung cancer group than in benign placeholder lesions group. P 〈 0. 01. The difference was statistically significant. Conclusion Lung cancer pathogenesis and EGFR gene mutations, tumor markers high expression was significantly positive correlation. Through a series of tumor markers and EGFR mutation testing, combined with imaging examination, it will contribute to the diagnosis and differential diagnosis in lung placeholder lesions, and provide the basis for treatment.

关 键 词：肺恶性肿瘤 EGFR基因 基因突变 肿瘤标志物 吸烟指数 

分 类 号：R734.2[医药卫生—肿瘤]